AMAG Stock Closes Down 17% After Failed Phase 3 Trial
On Friday, March 8th, AMAG Pharmaceuticals (NASDAQ:AMAG) made an announcement that sent the AMAG stock into the red. The stock ended up closing the trading day down nearly 20%. Here’s what we know. AMAG Pharmaceuticals ... [Read]